SCHEMBL4911906

SCHEMBL4911906

CCN(c1coc(-c2ccc(C(F)(F)F)cc2)n1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.39
PPARG P37231 5/20 0.38
PPARA Q07869 5/20 0.38
LMNA P02545 1/20 0.37
TRPM8 Q7Z2W7 3/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PPARD Q03181 3/20 0.35
S1PR1 P21453 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
KDM1A O60341 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907412 0.92 HCRTR2 (0.36) HDAC8PPARGPPARALMNATRPM8
SCHEMBL4903873 0.91 HDAC8 (0.38) HDAC8PPARGPPARAUSP2SMN1; SMN2
SCHEMBL4906508 0.90 LMNA (0.41) HDAC8PPARGPPARALMNATRPM8
SCHEMBL4900885 0.86 PPARG (0.43) HDAC8PPARGPPARALMNATRPM8
SCHEMBL4895724 0.83 PPARG (0.38) HDAC8PPARGPPARASMN1; SMN2PPARD
SCHEMBL4906847 0.83 ALDH1A1 (0.38) HDAC8PPARGPPARALMNAUSP2
SCHEMBL4897635 0.83 HDAC8 (0.53) HDAC8PPARGPPARALMNAPPARD
SCHEMBL4897582 0.81 LMNA (0.40) HDAC8PPARGPPARALMNATRPM8
SCHEMBL4903608 0.80 PPARG (0.41) HDAC8PPARGPPARALMNAUSP2
SCHEMBL4901379 0.79 KDM4E (0.41) HDAC8PPARGPPARALMNATRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885PPARG 2/4885PPARA 1/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885PPARG 2/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.